Início › Linfoma Difuso de Grandes Células B › Utah › Salt Lake City
Ensaios clínicos de Linfoma Difuso de Grandes Células B em Salt Lake City, UT
12 estudos para Linfoma Difuso de Grandes Células B estão buscando participantes em locais em Salt Lake City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RecrutandoFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- Intermountain Health LDS Hospital, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecrutandoFase 1
- Intermountain Healthcare, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecrutandoFase 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
RecrutandoFase 1
- Huntsman Cancer Institute, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecrutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecrutandoFase 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RecrutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
RecrutandoFase 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecrutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RecrutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RecrutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
RecrutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Ensaios de Linfoma Difuso de Grandes Células B em outras cidades
- New York City, NY21 estudos
- Baldwin Park, CA19 estudos
- Chicago, IL18 estudos
- Houston, TX17 estudos
- Los Angeles, CA17 estudos
- Boston, MA16 estudos
- Milwaukee, WI16 estudos
- Nashville, TN15 estudos
- Portland, OR15 estudos
- Philadelphia, PA15 estudos
- Durham, NC14 estudos
- Dallas, TX13 estudos
Outros estudos em Salt Lake City
- Câncer de Pulmão de Não Pequenas Células31 estudos
- Câncer (todos os tipos)27 estudos
- Câncer de Mama27 estudos
- Câncer Colorretal21 estudos
- Câncer de Pulmão21 estudos
- Mieloma Múltiplo21 estudos
- Melanoma21 estudos
- Câncer Metastático20 estudos
- Câncer de Ovário19 estudos
- Obesidade18 estudos
- Leucemia Mieloide Aguda17 estudos
- Insuficiência Cardíaca17 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.